Skip to main content
Journal of Toxicologic Pathology logoLink to Journal of Toxicologic Pathology
. 2021 Feb 27;34(2):151–156. doi: 10.1293/tox.2020-0079

Orbital malignant schwannoma and embryonal rhabdomyosarcoma in rats caused by leakage of locally injected nickel subsulfide to the orbit

Yoshinori Yamagiwa 1,2,*, Miki Masatsugu 1, Haruna Tahara 1, Kotaro Yamada 1, Yu Haranosono 1, Masaaki Kurata 1, Hiroshi Satoh 2,*
PMCID: PMC8100253  PMID: 33976471

Abstract

Nickel subsulfide (Ni3S2) is known to induce intraocular neoplasms when injected intravitreally into the eyes of rats. Here, we found two extraocular orbital neoplasms in two different rat strains, presumably due to the leakage of locally injected Ni3S2 to the extraocular orbital tissues. In the F344/DuCrlCrlj rat, an orbital mass arose at 30 weeks after injection, and invaded into the cranium. Histologically, the orbital mass was composed of areas arranged in parallel bundles formed by densely packed elongated or spindle-shaped cells with indistinct cytoplasmic borders, and of areas of hypocellular arrangement consisting of round cells in eosinophilic myxoid-like substances. Metastases were observed in the right submandibular and cervical lymph nodes. The neoplastic cells were immunopositive for S-100 protein and vimentin. Transmission electron microscopy revealed that the neoplastic cells had cellular processes and pericytoplasmic basal laminae. In the RccHanTM:WIST rat, an orbital mass arose at 36 weeks after injection. Histologically, the mass consisted of rhabdoid-like large round cells with proliferation of small round-to-polygonal cells, and these neoplastic cells infiltrated into the extraocular muscles. Immunohistochemically, the neoplastic cells were positive for desmin and vimentin. Transmission electron microscopy detected immature myofibrils with Z-band structures in the cytoplasm of these neoplastic cells. Consequently, the tumors were diagnosed as an orbital malignant schwannoma in an F344/DuCrlCrlj rat and an orbital embryonal rhabdomyosarcoma in a RccHanTM:WIST rat. The results of this case report suggest that leakage of Ni3S2 to the orbit caused the induction of orbital malignant schwannoma or rhabdomyosarcoma in rats.

Keywords: nickel subsulfide, orbital neoplasm, malignant schwannoma, rhabdomyosarcoma, rat


Intravitreal injection of nickel subsulfide (Ni3S2) is known to induce intraocular neoplasms in Fischer rats1. Although several spontaneous orbital neoplasms have been reported in rats2, 3, 4, 5, 6, to the best of our knowledge, chemical-induced orbital neoplasms have not been reported to date. Here, we found orbital neoplasms in F344/DuCrlCrlj (F344) and RccHanTM:WIST (Wistar Han) rats, presumably caused by the leakage of locally injected Ni3S2 to the extraocular orbital tissues. In this report, we characterized their histopathological features of two orbital neoplasms in rats.

The F344 (hereafter Case 1) and Wistar Han (hereafter Case 2) rats received a single intravitreal injection of Ni3S2 (Sigma-Aldrich, St. Louis, MO, USA) at 5 weeks of age to investigate ocular carcinogenesis. Prior to injection, Ni3S2 was suspended in physiological saline (Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan) at a concentration of 50 mg/mL. Ten microliters of the Ni3S2 suspension was aspirated into a 50 µL Hamilton ultraprecise microsyringe (Hamilton Company, Reno, NV, USA) under continuous agitation with a magnetic stirrer, followed by immediate injection into the vitreous of the right eyes of 10 F344 and 14 Wistar Han rats at a dose of 0.5 mg/eye using a 30 G needle (Dentronics, Tokyo, Japan). Despite this dosing procedure, the concentration of Ni3S2 could not be precisely controlled because Ni3S2 particles partially sedimented within the microsyringe lumen during administration. The rats were housed in plastic cages at a controlled temperature of 23 ± 3°C and relative humidity of 55 ± 10% under a 12-h/12-h light/dark cycle in conventional animal rooms. All animals were given a commercial diet, Labo MR Stock (Nosan Corporation, Kanagawa, Japan), and tap water ad libitum. All experimental procedures were conducted in compliance with the guidelines for animal welfare at Senju Pharmaceutical Co., Ltd. The study adhered to the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research. The study protocol was reviewed and approved by the Institutional Animal Care and Use Committee. Ophthalmological examinations that included anterior ocular observation and fundus observation were performed prior to dosing, one week after the treatment, and once per month thereafter using a slit-lamp biomicroscope, SL-17 (Kowa Company Ltd., Tokyo, Japan) and a binocular indirect ophthalmoscope, IO-α (Neitz Instruments Co., Ltd., Tokyo, Japan). When excessive abnormalities were observed around the eyes in rats of either Cases, the animals were euthanized by exsanguination via the abdominal aorta under inhalation anesthesia of sevoflurane (Mylan Inc., Canonsburg, PA, USA). Following euthanasia, the detected orbital masses were enucleated and immersed in 10% (v/v) neutral-buffered formalin (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) for fixing. In Case 1, the skull, brain, right cranial nerve, and swollen right submandibular and cervical lymph nodes were also collected. The skull was decalcified in 5% formic acid/formalin solution for seven days before sectioning. After fixation, the tissues were embedded in paraffin, and sagittal sections of approximately 3 µm thickness were prepared and stained with hematoxylin and eosin (HE). In Case 2, phosphotungstic acid-hematoxylin (PTAH) staining was also performed. Tissue sections of the orbital masses were stained with S-100 protein 4B3 (mouse monoclonal, ab14849, Abcam Plc., Cambridge, UK), α-smooth muscle actin 1A4 (α-SMA, mouse monoclonal, ab7817, Abcam Plc.), neuron-specific enolase (NSE, rabbit polyclonal, ab53025, Abcam Plc.), vimentin V9 (mouse monoclonal, V6630, Sigma-Aldrich), desmin D33 (mouse monoclonal, 413651, Nichirei Biosciences Inc., Tokyo, Japan, only for Case 2), pan-cytokeratin AE1+AE3 (CK, NBP2-29429, Novus biologicals LLC, Centennial, CO, USA) and Melan-A M2-9E3 (mouse monoclonal, ab187369, Abcam Plc.). The immunohistochemical sections were counterstained with Mayer’s hematoxylin solution (FUJIFILM Wako Pure Chemical Corporation). For transmission electron microscopy, a segment of each orbital mass was collected and fixed with 2.5% (v/v) glutaraldehyde in 0.1 M phosphate buffer. The samples were then rinsed several times with 3% (w/v) sucrose in 0.1 M phosphate buffer and postfixed with 1% (w/v) osmium tetroxide. Following fixation, the tissues were embedded in epoxy resin, ultrathin-sectioned, and double-stained with lead citrate and uranyl acetate. The sections were examined under H-300 transmission electron microscope (Hitachi Ltd., Tokyo, Japan).

In Case 1, the ophthalmological examination detected exophthalmos and projection around the palpebral fissure in the Ni3S2-treated (right) eye at 30 weeks after the treatment. In addition, dryness, dark-red deposits on the ocular surface, loss of lighting reflex, incomplete mydriasis, narrowing of iridal vessel, and diffuse lens opacity were also observed. However, owing to lens opacity, fundus could not be observed. Case 1 animal was euthanized and necropsied at 31 weeks after the treatment due to excessive projection around the palpebral fissure. Necropsy examination revealed that the right orbit was filled with a milky-white mass, following which the right eyeball was extruded. The mass was observed in the cranial cavity as well, wherein the adjacent right trigeminal nerve was found swollen (Fig. 1A). Right submandibular and cervical lymph nodes were also swollen. Further, histopathological examination revealed that the orbital mass was composed of neoplastic cells, that were filling the orbital cavity and had destroyed the original orbital structure. The neoplastic cells infiltrated into the conjunctiva and eyelid (Fig. 1B) or invaded into the cranium by destroying the orbital bone tissue (Fig. 1C). Boundary of the mass was not clearly demarcated. The orbital mass was composed of areas arranged in parallel bundles formed by densely packed elongated or spindle-shaped cells with indistinct cytoplasmic borders (Antoni type A) (Fig. 1D), and of areas of hypocellular arrangement consisting of round cells in abundant eosinophilic myxoid-like substances (Antoni type B) (Fig. 1E). Mitotic figures were rare in both the areas. In the right submandibular lymph nodes, the sinus was filled with spindle-shaped neoplastic cells and the lymph node was swollen (Fig. 1F). The neoplastic cells had round-to-oval nuclei, and proliferated with the intercellular fibrous structure. Based on these characteristics, the lesions in the lymph nodes were identified as orbital metastases. In the immunohistochemical examination, the neoplastic cells were found positive for S-100 protein (Fig. 1G) and vimentin (Fig. 1H), and negative for CK, α-SMA, Melan-A, and NSE in the both the areas. Transmission electron microscopy showed oval-to-rod-shaped nuclei in the neoplastic cells. Further, these cells contained cytoplasmic organelles, including mitochondria, free ribosomes, and occasionally expanded endoplasmic reticulum. Notably, some cells had long or short cellular processes (Fig. 1I). The electron-dense basal laminae were sparsely distributed in the pericytoplasmic region of the neoplastic cells (Fig. 1J). Occasionally, fibrous structures were observed in the intercellular spaces. The orbital mass consisted of proliferative neoplastic cells showing invasive growth to the surrounding tissues. In addition, regional lymph node metastases were observed, indicating that the mass was indeed a malignant neoplasm. Considering these histopathological, immunohistochemical, and ultrastructural findings, the orbital mass was diagnosed as an orbital malignant schwannoma with right submandibular and cervical lymph node metastases. Case 1 animals exhibited characteristic cellular arrangements, such as presence of Antoni type A and B, cellular processes, and pericytoplasmic basal laminae, along with the neoplastic cells testing positive for S-100 protein and vimentin. Unfortunately, the origin of the neoplasm could not be determined since most of the orbital tissues were destroyed by the proliferative neoplastic cells. However, the nerve fibers, such as ophthalmic or ciliary nerves, were distributed in the orbit, suggesting that the tumor was presumably from the nerve sheath.

Fig. 1.

Fig. 1.

Case 1: An orbital malignant schwannoma in an F344 rat arising at 31 weeks after injection of nickel subsulfide to the orbit. A milky-white mass (arrows) fills the right orbit and invades the cranium (A). Right trigeminal nerve is swollen (A inset). The mass fills the orbit and the neoplastic cells infiltrate into the conjunctiva and eyelid (B), or the cranium (Cr) and nasal cavity (NC) (C). The mass is composed of areas arranged in parallel bundles formed by densely packed elongated or spindle-shaped cells with indistinct cytoplasmic borders (Antoni type A) (D), or a hypocellular arrangement consisting of round cells in eosinophilic myxoid-like substances (Antoni type B) (E). Right submandibular lymph nodes are filled with the spindle-shaped neoplastic cells (F) and are grossly swollen (F inset). The neoplastic cells are positive for S-100 protein (G) and vimentin (H). Transmission electron micrographs show that the neoplastic cells have cellular processes (arrowhead) (I), or electron-dense pericytoplasmic basal laminae (open arrows) (J). HE staining (B–F) and immunohistochemical staining of S-100 protein (G) or vimentin (H), and transmission electron micrographs (I, J). Scale bars = 50 µm (D–H), 2 µm (I), and 400 nm (J).

In Case 2, a right orbital mass was first found at 36 weeks after the treatment. Prior to the appearance of this orbital mass, vitreal linear structure, and crystalline materials were observed from 22 weeks after the treatment. The animal was euthanized and necropsied at 37 weeks after the treatment owing to excessive enlargement of the right orbital mass. Necropsy examination revealed an ivory-to-grayish-colored mass filled in the right orbit, following which the right eyeball was extruded. Histopathological examination revealed that the mass consisted of proliferative neoplastic cells with some necrotic foci, and destroyed original orbital tissues (Fig. 2A). The neoplastic cells infiltrated into the extraocular muscles, and the muscle fibers were atrophied (Fig. 2B). In addition, the neoplastic cells infiltrated into the right eyeball. It was found that the neoplastic cells were composed of plump rhabdoid-like large round cells and relatively small round-to-polygonal cells (Fig. 2C). In higher magnification, the plump rhabdoid-like cells had one or a few round nuclei with a prominent pale or fibrillary eosinophilic cytoplasm. The proliferated round-to-polygonal cells had one nucleus with poor cytoplasm (Fig. 2D). Mitotic figures were occasionally observed. The neoplastic cells had no clear striations in the cytoplasm even in the PTAH-stained section. Immunohistochemistry showed that the neoplastic cells were strongly positive for desmin (Fig. 2E), weakly positive for vimentin (Fig. 2F), and negative for CK, α-SMA, Melan-A, NSE, and S-100 protein. In the transmission electron microscopy, the rhabdoid-like large round cells were identified as plump rhabdomyoblast-like cells that had one or a few round-to-elliptic nuclei with abundant cytoplasm containing organelles such as mitochondria (Fig. 2G). The small round-to-polygonal cells were recognized as relatively small rhabdomyoblast-like cells. The plump rhabdomyoblast-like cells had randomly arranged immature myofibrils with Z-band structures in the cytoplasm (Fig. 2H). The mass was composed of proliferative neoplastic cells that showed cellular pleomorphism, and invasive growth to the extraocular muscles and the other orbital tissues, indicating that the mass was indeed a malignant neoplasm. Even though no clear striations were observed in the PTAH-stained section, the neoplastic rhabdoid-like cells were immunopositive for desmin and vimentin, and had Z-band structures in the cytoplasm, as detected by transmission electron microscopy. In addition, the neoplasm contained a large number of small, undifferentiated round-to-polygonal cells with proliferation of rhabdoid-like large round cells, which is a typical embryonal variant. Based on these histological, immunohistochemical, and ultrastructural findings, the mass was diagnosed as an orbital embryonal rhabdomyosarcoma. The neoplastic cells intensively infiltrated into the skeletal muscle fibers in the orbit, suggesting that the neoplasm originated from the extraocular muscles.

Fig. 2.

Fig. 2.

Case 2: An orbital embryonal rhabdomyosarcoma in a Wistar Han rat arising at 37 weeks after injection of nickel subsulfide to the orbit. A mass is located behind the eye, and some necrotic areas can be observed (A). The neoplastic cells infiltrate into the extraocular muscles (B). The mass consists of rhabdoid-like large round cells with proliferation of small round-to-polygonal cells (C). The rhabdoid-like cells have one or a few round nuclei with prominent pale or fibrillary eosinophilic cytoplasm, and the round-to-polygonal cells have one nucleus with relatively poor cytoplasm (D). The rhabdoid-like cells are strongly positive for desmin (E) and weakly positive for vimentin (F). Transmission electron microscopy identities the rhabdoid-like large round cells as plump rhabdomyoblast-like neoplastic cells (G) that contain immature myofibrils with Z-band structures in the cytoplasm (H). HE staining (A–D), immunohistochemical staining of desmin (E) or vimentin (F), and transmission electron micrographs (G, H). Scale bars = 200 µm (B), 50 µm (C–F), 2 µm (G), and 200 nm (H).

No orbital neoplasms were observed in the other animals treated with intravitreal injection of Ni3S2. Intraocular neoplasms were induced in other two Wistar Han rats.

Generally, spontaneous orbital/intracranial neoplasms are rare in rats of such young age. Incidences of orbital neoplastic changes in either Wistar Han or F344 rats including young ones have not been recorded in recent historical control data of several test facilities7, 8, 9, 10, 11, 12. Similarly, no early spontaneous orbital/intracranial neoplasm in Sprague–Dawley rats has been recorded in recent historical control data13, 14. However, in aged F344 rats, spontaneous intraocular and orbital schwannomas have been reported5. Some case reports in Sprague–Dawley rats have described orbital amelanotic melanoma in a 67-week-old animal6 and trigeminal nerve-derived intracranial schwannomas in 19- and 28-week-old animals15, 16. To the best of our knowledge, orbital rhabdomyosarcoma has not been previously reported as spontaneous neoplasm in rats. The neoplastic changes did not arise in the orbit in the untreated left eyes in this study. These facts suggest that the two extraocular orbital neoplasms were treatment-related, and not spontaneous lesions.

In a previous study, intravitreal injection of Ni3S2 in F344 rats induced intraocular neoplasms including retinoblastoma, glioma, and melanoma1. However, extraocular orbital neoplasms were not described then. By administering Ni3S2 to F344 rats via several dosing routes, the neoplasms arose around the areas of administration sites17, 18. Intramuscular injection of Ni3S2 is known to induce rhabdomyosarcoma in F344 or Wistar rats19, 20, 21. These results suggest that Ni3S2 poses carcinogenic potential when in contact with the tissues of these animals. In the present study, a possible cause of induction of orbital neoplastic changes is that Ni3S2 leaked into the extraocular orbital tissues following accidental injection by perforation of needles and affected the orbital Schwann cells or the skeletal muscles. The results of this case report suggest that leakage of locally injected Ni3S2 to the orbit underlies the induction of orbital malignant schwannoma or rhabdomyosarcoma in rats.

Disclosure of Potential Conflicts of Interest

The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Acknowledgments

The authors thank Mr. Yoshihiro Takei and the staff of Ina Research Inc. for their help in preparing the specimens for histopathological and ultrastructural examination. Their dedication and excellent efforts made these investigations possible.

References

  • 1.Albert DM, Gonder JR, Papale J, Craft JL, Dohlman HG, Reid MC, and Sunderman FW, Jr . Induction of ocular neoplasms in Fischer rats by intraocular injection of nickel subsulfide. Invest Ophthalmol Vis Sci. 22: 768–782. 1982. [PubMed] [Google Scholar]
  • 2.Ackerman LJ, Yoshitomi K, Fix AS, and Render JA. Proliferative lesions of the eye in rats, OSS. In: Guides for Toxicologic Pathology. STP/ARP/AFIP, Washington, DC. 1–14. 1998. [Google Scholar]
  • 3.Dunn DG, Baker JFM, and Sorden SD. Eye and associated glands. In: Boorman’s Pathology of the Rat, Reference and Altras, 2nd ed. AW Suttie, JR Leininger, and AE Bradley (eds). Academic Press, New York. 251–278. 2018. [Google Scholar]
  • 4.Yoshitomi K, and Boorman GA. Eye and associated glands. In: Pathology of the Fischer Rat, Reference and Atlas. GA Boorman, SL Eustis, MR Elwell, CA Montgomery Jr, and WF MacKenzie (eds). Academic Press, New York. 239–259. 1990. [Google Scholar]
  • 5.Yoshitomi K, and Boorman GA. Intraocular and orbital malignant schwannomas in F344 rats. Vet Pathol. 28: 457–466. 1991. [DOI] [PubMed] [Google Scholar]
  • 6.Kurotaki T, Tomonari Y, Kanno T, Wako Y, and Tsuchitani M. Malignant amelanotic melanoma behind the left eye in a female Crj:CD(SD)IGS rat: a case report. Vet Pathol. 45: 681–684. 2008. [DOI] [PubMed] [Google Scholar]
  • 7.Hojo M, Sakamoto Y, Maeno A, Tayama K, Tada Y, Yuzawa K, Ando H, Kubo Y, Nagasawa A, Tanaka K, Yano N, Kaihoko F, Hasegawa Y, Suzuki T, Inomata A, Moriyasu T, Miyajima K, and Nakae D. A histopathological analysis of spontaneous neoplastic and non-neoplastic lesions in aged male RccHan:WIST rats. J Toxicol Pathol. 33: 47–55. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Kuroiwa Y, Ando R, Kasahara K, Nagatani M, Yamakawa S, and Okazaki S. Transition of historical control data for high incidence tumors in f344 rats. J Toxicol Pathol. 26: 227–230. 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Iwata H, Hirouchi Y, Koike Y, Yamakawa S, Kobayashi K, Yamamoto T, Kobayashi K, Inoue H, and Enomoto M. Historical control data of nonneoplastic and neoplastic lesions in F344/DuCrj rats. J Toxicol Pathol. 4: 1–24. 1991. [Google Scholar]
  • 10.Hayakawa K, Mimura Y, Tachibana S, Furuya M, Kodama T, Aoki T, Hosokawa S, Fukui M, Shibata S, Yoshida M, Masuyama T, Narita T, Kuwagata M, Hisada S, and Maki E. Study for collecting background data on Wistar Hannover [Crl:WI(Han)] rats in general toxicity studies--comparative data to Sprague Dawley rats. J Toxicol Sci. 38: 855–873. 2013. [DOI] [PubMed] [Google Scholar]
  • 11.Okamura T, Suzuki S, Ogawa T, Kobayashi J, Kusuoka O, Hatayama K, Mochizuki M, Hoshiya T, Okazaki S, and Tamura K. Background data for general toxicology parameters in RccHan:WIST rats at 8, 10, 19 and 32 weeks of age. J Toxicol Pathol. 24: 195–205. 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Son WC, Bell D, Taylor I, and Mowat V. Profile of early occurring spontaneous tumors in Han Wistar rats. Toxicol Pathol. 38: 292–296. 2010. [DOI] [PubMed] [Google Scholar]
  • 13.Son WC, and Gopinath C. Early occurrence of spontaneous tumors in CD-1 mice and Sprague-Dawley rats. Toxicol Pathol. 32: 371–374. 2004. [DOI] [PubMed] [Google Scholar]
  • 14.Ikezaki S, Takagi M, and Tamura K. Natural occurrence of neoplastic lesions in young sprague-dawley rats. J Toxicol Pathol. 24: 37–40. 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yoshizawa K, Oishi Y, Makino N, Suzuki J, Matsumoto M, Yamauchi K, Fujihira S, and Fujii T. Malignant schwannoma of the intracranial trigeminal nerve in a 19-week-old female Sprague-Dawley rat. J Toxicol Pathol. 9: 107–112. 1996. [Google Scholar]
  • 16.Nagatani M, Yamakawa S, Ando R, Edamoto H, Saito T, and Tamura K. Highly invasive intracranial malignant schwannoma in a rat. J Toxicol Pathol. 22: 139–142. 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Shibata M, Izumi K, Sano N, Akagi A, and Otsuka H. Induction of soft tissue tumours in F344 rats by subcutaneous, intramuscular, intra-articular, and retroperitoneal injection of nickel sulphide (Ni3S2). J Pathol. 157: 263–274. 1989. [DOI] [PubMed] [Google Scholar]
  • 18.Sunderman FW. Recent research on nickel carcinogenesis. Environ Health Perspect. 40: 131–141. 1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yamashiro S, Gilman JPW, Basrur PK, and Abandowitz HM. Growth and cytogenetic characteristics of nickel sulphide-induced rhabdomyosarcomas in rats. Acta Pathol Jpn. 28: 435–444. 1978. [DOI] [PubMed] [Google Scholar]
  • 20.Yamashiro S, Basrur PK, Gilman JPW, Hulland TJ, and Fujimoto Y. Ultrastructural study of Ni3S2-induced tumors in rats. Acta Pathol Jpn. 33: 45–58. 1983. [DOI] [PubMed] [Google Scholar]
  • 21.Hildebrand HF, and Biserte G. Ultrastructural investigation of NI3S2-induced rhabdomyosarcoma in Wistar rat: comparative study with emphasis on myofibrillar differentiation and ciliar formation. Cancer. 42: 528–554. 1978. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Toxicologic Pathology are provided here courtesy of The Japanese Society of Toxicologic Pathology

RESOURCES